Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Medications used for weight loss, such as Ozempic, Wegovy, Mounjaro, and Zepbound, are taking over the pharmaceutical industry. While Eli Lilly and Novo Nordisk are the big players in diabetes and obesity care thanks to their glucagon-like peptide-1 (GLP-1) agonists, there are a
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1460688324-f16440d2897546b59d37b4480059ca94.jpg "<div>Rolling Over Company Stock from a 401(k): When It Does—and Doesn't—Make Sense</div>")